National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 10/8/2021 release of VAERS data:

This is VAERS ID 1161735



Case Details

VAERS ID: 1161735 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-04-02
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL0203 / 2 - / -

Administered by: Other       Purchased by: ?
Symptoms: Asthenia, Death, General physical health deterioration, Leukocytosis, Oxygen saturation, White blood cell count
SMQs:, Neuroleptic malignant syndrome (broad), Guillain-Barre syndrome (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Anemia; Chronic bronchitis; Hypertension; Osteoporosis; Smoker
Allergies:
Diagnostic Lab Data: Test Name: oxygen saturation; Result Unstructured Data: Test Result:96; Test Name: leukocytes; Result Unstructured Data: Test Result:17000; Comments: leukocytosis
CDC Split Type: ILPFIZER INC2021330471

Write-up: decrease in general state; weakness; leukocytosis 17000; Died in the hospital; This is a spontaneous report from a contactable other healthcare professional received via the Agency Regulatory Authority, Regulatory Authority report number is unspecified. An 85-year-old female patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration on an unspecified date (Lot Number: EL0203) as single dose for COVID-19 immunization. Medical history included, hypertension, heavy smoker in the past, chronic bronchitis, osteoporosis, anemia. The patient''s concomitant medications were not reported. The patient previously received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on an unspecified date (Lot Number: unknown) as single dose for COVID-19 immunization. The patient "came to the emergency room as a of decrease in the general state and weakness for a week now. Saturation with oxygen 96, lab tests- leukocytosis 17000- started empirical antibiotic treatment. Died in the hospital." The patient was hospitalized for events decrease in the general state, weakness, leukocytosis. Emergency room visit for "decrease in the general state" and weakness (for a week now). The patient underwent lab tests and procedures which included oxygen saturation: 96, white blood cell count: 17000 (leukocytosis) on an unspecified date. Therapeutic measures were taken as a result of leukocytosis 17000 which included empirical antibiotic treatment. The outcome of the events decrease in the general state, weakness, leukocytosis was unknown. The patient died on an unspecified date. It was not reported if an autopsy was performed. No follow-up attempts are possible. No further information is expected. Batch/lot number already provided.; Reported Cause(s) of Death: Died in the hospital


New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?IDNUMBER=1161735

Government Disclaimer on use of this data


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166